HK inno.N Corporation clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-19
What changed in the last 30 days
1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
New trial filings, last 30 days
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-11-12 | NCT07930247 Blood Pressure Control and Safety of Ex-one or Ex-one Plus in Essential Hypertension | Recruiting | |
| 2026-11-12 | NCT07930260 Efficacy and Safety of Kabalin Cap.(Pregabalin) in Patients With Neuropathic Pain | Recruiting | |
| 2026-11-10 | NCT07930169 Observational Study to Evaluate the Safety and Efficacy of Kremezin IDT/Fine Gran in… | Recruiting | |
| 2026-11-09 | NCT07924345 Observational Study to Evaluate Achieving LDL-cholesterol Target Level to Treat With… | Recruiting | |
| 2026-11-06 | NCT07920679 Efficacy and Safety of K-CAB(Tegoprazan) 25 mg as Maintenance Therapy Following the… | Recruiting |
Active trials by phase
| Phase 1 | 5 | |
| Phase 2 | 2 | |
| Phase 3 | 2 | |
| Phase 4 | 1 |
Not charted: 7 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).
Disease areas by active trials
Atopic Dermatitis (1) · Atrial Fibrillation (1) · Chronic Kidney Disease (1) · Diabetes (1) · Heart Disease (1) · Hypertension (1) · Obesity (1) · Type 2 Diabetes (1)
Get alerts when HK inno.N Corporation's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.